ArticlePharmaceuticals (Basel, Switzerland)2024

Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor.

Aya Soudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.